14-day Premium Trial Subscription Sign Up For FreeGet Free

Acorda Therapeutics Stock Forecast NASDAQ:ACOR

Price Target and Analyst Ratings

Most Recent Rating

On July 27, 2021 "HC Wainwright" gave "$10.00" rating for ACOR. The price target was changed from $3.96 to 7.7%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-07-27 $10.00 Reiterated by HC Wainwright $3.96 $3.96→7.7%
2021-06-17 $5.00 - $10.00 Upgraded by HC Wainwright $4.85 $4.21→3.6%
2021-06-17 Neutral - Buy Upgraded by HC Wainwright $4.85 $5.00 → $10.00
2021-01-13 Target Raised by Cowen $6.12 $5.00 → $35.00
2020-08-11 Hold Reiterated by Jefferies Financial Group $0.71 $1.00
2020-05-06 Neutral Reiterated by HC Wainwright $0.86 $6.00 → $5.00

ACOR Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $4.94 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -6.01% during the next 3 months and, with a 90% probability hold a price between $3.04 and $4.65 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $3.22 $4.08 $4.94
2021-09-21 $3.22 $4.08 $4.93
2021-09-22 $3.21 $4.07 $4.93
2021-09-23 $3.21 $4.07 $4.92
2021-09-24 $3.20 $4.06 $4.92
2021-09-27 $3.20 $4.06 $4.91
2021-09-28 $3.19 $4.05 $4.91
2021-09-29 $3.19 $4.05 $4.90
2021-09-30 $3.18 $4.04 $4.90
2021-10-01 $3.18 $4.04 $4.89
2021-10-04 $3.17 $4.03 $4.89
2021-10-05 $3.17 $4.03 $4.88
2021-10-06 $3.16 $4.02 $4.88
2021-10-07 $3.16 $4.02 $4.87
2021-10-08 $3.15 $4.01 $4.87
2021-10-11 $3.15 $4.01 $4.86
2021-10-12 $3.14 $4.00 $4.86
2021-10-13 $3.14 $4.00 $4.85
2021-10-14 $3.13 $3.99 $4.85
2021-10-15 $3.13 $3.99 $4.84
2021-10-18 $3.12 $3.98 $4.84
2021-10-19 $3.12 $3.98 $4.83
2021-10-20 $3.11 $3.97 $4.83
2021-10-21 $3.11 $3.97 $4.82
2021-10-22 $3.10 $3.96 $4.82
2021-10-25 $3.10 $3.96 $4.81
2021-10-26 $3.09 $3.95 $4.81
2021-10-27 $3.09 $3.95 $4.80
2021-10-28 $3.08 $3.94 $4.80
2021-10-29 $3.08 $3.94 $4.79

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT